白内障术后眼内炎23年微生物谱与临床表现变化趋势
该回顾性比较队列研究纳入法国2个三级转诊中心234眼急性白内障术后眼内炎,比较2002—2007年与2016—2025年两个时期的病原谱、耐药谱及临床严重程度。近期队列凝固酶阴性葡萄球菌比例下降、粪肠球菌与革兰阴性菌比例上升,头孢呋辛耐药与甲氧西林耐药均显著增加,但临床起病表现较轻。
要点
- 近期队列凝固酶阴性葡萄球菌占比由38%降至25%,粪肠球菌由2%升至10%。
- 头孢呋辛耐药由26.0%升至66.1%,葡萄球菌甲氧西林耐药由30.3%升至75.0%。
- 近期队列起病时视力≥20/400者占29.0%、可见眼底者占24.1%,表现较轻。
核心结论
- 23年间急性白内障术后眼内炎病原谱明显变迁,凝固酶阴性葡萄球菌减少而粪肠球菌增多,头孢呋辛与甲氧西林耐药增加。
- 需持续进行微生物学监测以指导经验性治疗和未来预防策略。
研究设计与样本
- 回顾性比较队列研究,纳入法国2个三级转诊中心白内障术后6周内就诊的234眼(234例患者)。
- 历史队列为2002—2007年管理的126眼,近期队列为2016—2025年管理的108眼。
- 微生物分析包括房水和/或玻璃体样本的传统培养与16S聚合酶链反应,并对细菌分离株行抗菌药物敏感性试验。
主要发现
- 细菌鉴定率历史队列为85/126眼(67.5%),近期队列为63/108眼(58.3%)。
- 凝固酶阴性葡萄球菌占眼内炎病例比例由38%降至25%,粪肠球菌由2%升至10%,革兰阴性菌由3.1%升至7.3%。
- 近期队列起病时视力≥20/400者为29.0%对11.2%,可见眼底者为24.1%对9.6%,行平坦部玻璃体切割术者为51.9%对63.5%。
关键数值与推荐
- 头孢呋辛耐药由26.0%(13/50)升至66.1%,校正OR为3.75(95%CI 1.59-8.82,P=.003)。
- 葡萄球菌中甲氧西林耐药由30.3%升至75.0%,校正OR为6.75(95%CI 1.99-22.83,P=.002)。
- 多重耐药表型由3.0%升至37.5%(P=.003)。
临床怎么用
- 经验性治疗应考虑头孢呋辛耐药及甲氧西林耐药葡萄球菌增多,结合本地微生物监测选择抗菌方案。
- 即使近期队列起病表现较轻,仍需警惕粪肠球菌和革兰阴性菌比例上升带来的治疗挑战。
局限性
- 回顾性设计限制解释。
- 药敏数据不完整。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To characterize temporal changes in clinical severity, bacterial spectrum, and antimicrobial susceptibility in acute postcataract endophthalmitis over 23 years. DESIGN: Retrospective comparative cohort study. SUBJECTS, PARTICIPANTS, AND/OR CONTROLS: This study included 234 eyes of 234 patients presenting within 6 weeks after cataract surgery at 2 French tertiary referral centers. The historical cohort comprised 126 eyes managed from 2002 through 2007, and the recent cohort comprised 108 eyes managed from 2016 through 2025. METHODS, INTERVENTION, OR TESTING: Microbiological analyses included conventional cultures and 16S polymerase chain reaction on aqueous and/or vitreous samples. Antimicrobial susceptibility testing was performed on bacterial isolates. Baseline clinical severity, pathogen distribution, and resistance profiles were compared between cohorts. MAIN OUTCOME MEASURES: Pathogen distribution, cefuroxime susceptibility, methicillin resistance among staphylococci, and markers of clinical severity at presentation. RESULTS: Bacterial identification was obtained in 85 of 126 eyes (67.5%) in the historical cohort and 63 of 108 eyes (58.3%) in the recent cohort. Coagulase-negative staphylococci decreased from 38% to 25% of endophthalmitis cases, whereas Enterococcus faecalis increased from 2% to 10%; Gram-negative bacteria increased from 3.1% to 7.3%. Cefuroxime resistance increased from 26.0% (13/50) to 66.1% (adjusted odds ratio [OR], 3.75; 95% confidence interval [CI], 1.59-8.82; P = .003) of tested isolates. Among staphylococci, methicillin resistance increased from 30.3% to 75.0% (adjusted OR, 6.75; 95% CI, 1.99-22.83; P = .002), and multidrug-resistant phenotypes increased from 3.0% to 37.5% (P = .003). Eyes in the recent cohort had milder clinical presentation, with visual acuity of 20/400 or better in 29.0% vs 11.2%, visible fundus in 24.1% vs 9.6%, and pars plana vitrectomy performed in 51.9% vs 63.5%. Interpretation is limited by the retrospective design and incomplete susceptibility data. CONCLUSIONS: This retrospective comparative cohort study of 234 cases across 2 periods spanning 23 years was associated with a marked shift in the bacterial spectrum of acute postcataract endophthalmitis, with fewer coagulase-negative staphylococci and more E. faecalis isolates, alongside increased cefuroxime and methicillin resistance. Continued microbiological surveillance is warranted to guide empiric therapy and future prophylactic strategies.
引用
- Baudere A, Maurin M, Dot C, et al. Changing Trends in the Microbiological Spectrum and Clinical Presentation of Postcataract Endophthalmitis Over a 23-Year Period. Am J Ophthalmol. 2026. PMID: 42692132. doi:10.1016/j.ajo.2026.08.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。